Literature DB >> 28922321

Patient-Reported Outcomes following Breast Conservation Therapy and Barriers to Referral for Partial Breast Reconstruction.

Sebastian Q Vrouwe1,2, Ron B Somogyi1,2, Laura Snell1,2, Catherine McMillan1,2, Danny Vesprini1,2, Joan E Lipa1,2.   

Abstract

BACKGROUND: The purpose of this study was to evaluate the self-reported aesthetic outcome of breast conservation therapy in a generalized sample of patients, and to describe potential barriers to referral for partial breast reconstruction.
METHODS: Consecutive breast conservation therapy patients completing radiotherapy over a 1-year period at a regional cancer center were identified. Eligible patients were contacted by means of mail/e-mail and invited to participate. Participants completed the BREAST-Q breast conservation therapy module along with a questionnaire examining feelings about breast reconstruction. Multiple regression analysis was performed using the satisfaction with breasts scale as the dependent variable.
RESULTS: Surveys were completed by 185 of 592 eligible participants (response rate, 31.3 percent; mean age, 61 years) an average of 38 months after lumpectomy. The mean score for the BREAST-Q satisfaction with breasts scale was 59 of 100. Younger age (p = 0.038), lumpectomy reexcision (p = 0.018), and lumpectomy at a nonacademic center (p = 0.026) were significantly associated with lower satisfaction. Bra size, months from lumpectomy, and tumor quadrant/size were not significantly associated with satisfaction (p > 0.05). The most common statements regarding reconstruction were "I don't feel the need for it" (60.0 percent), "I don't like the thought of having breast implants" (22.7 percent), and "I don't want any more surgeon/doctor visits" (22.2 percent). Before lumpectomy, only 1.6 percent had a consultation for reconstruction, and only 22.7 percent were aware of this option. If offered, 33.1 percent of patients would have attended this consultation.
CONCLUSION: There is an unmet demand for partial breast reconstruction, with an opportunity to advocate and increase awareness on behalf of patients undergoing breast conservation therapy.

Entities:  

Mesh:

Year:  2018        PMID: 28922321     DOI: 10.1097/PRS.0000000000003914

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study.

Authors:  Kari M Rosenkranz; Karla Ballman; Linda McCall; Colleen McCarthy; Charlotte D Kubicky; Laurie Cuttino; Kelly K Hunt; Armando Giuliano; Kimberly J Van Zee; Bruce Haffty; Judy C Boughey
Journal:  Ann Surg Oncol       Date:  2020-07-22       Impact factor: 5.344

2.  Factors associated with completion of patient surveys 1 year after bariatric surgery.

Authors:  Rafael Alvarez; Amanda Stricklen; Colleen M Buda; Rachel Ross; Aaron J Bonham; Arthur M Carlin; Oliver A Varban; Amir A Ghaferi; Jonathan F Finks
Journal:  Surg Obes Relat Dis       Date:  2020-11-02       Impact factor: 4.734

3.  Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer.

Authors:  Michael Rose; Henry Svensson; Jürgen Handler; Ute Hoyer; Anita Ringberg; Jonas Manjer
Journal:  Breast Cancer Res Treat       Date:  2020-01-27       Impact factor: 4.872

4.  Satisfaction with the Aesthetic Effect and Quality of Life for Women after Breast Conserving Therapy (BCT)-Preliminary Research.

Authors:  Agata Krzos; Andrzej Stanisławek; Marian Jędrych; Marta Łuczyk; Barbara Ślusarska
Journal:  Int J Environ Res Public Health       Date:  2019-11-25       Impact factor: 3.390

5.  Well-Being, Depression, and Anxiety following Oncoplastic Breast Conserving Surgery versus Modified Radical Mastectomy Followed by Late Breast Reconstruction.

Authors:  Daciana Grujic; Cătălina Giurgi-Oncu; Cristina Oprean; Zorin Crăiniceanu; Ica Secoșan; Ioana Riviș; Ion Papavă; Corina Vernic; Cristina Bredicean
Journal:  Int J Environ Res Public Health       Date:  2021-09-03       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.